drugset / Trial / NCT03433859

Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)

NCT03433859 ↗

Phase 3 Completed 54 enrolled Central Directorate of the Army Health Service
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to demonstrate onabotulinumtoxinA superiority to aluminium chloride for the treatment of residual limb hyperhidrosis.

Timeline

Start
2016-03
Primary completion
2020-09-10
Completion
2021-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Other